2 most recent filings and news items mentioning EDSA. Updated every 60 seconds.
OfferingJun 11, 2026Positive
Edesa Biotech executed a securities purchase agreement dated June 10, 2026, to sell common shares and pre-funded warrants to accredited investors under Regulation D exemption. The offering provides capital funding and includes registration rights for the purchased securities unde
View filing at SEC.gov →
OtherMay 29, 2026Neutral
Edesa Biotech's board approved Amendment No. 5 to its 2019 Equity Incentive Compensation Plan, effective March 18, 2026, increasing reserved shares by 750,000 and eliminating annual option grant limits per participant. The amendments require shareholder approval at the 2026 Annua
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.